$DOW

DOW INC. (DOW): Results of Operations and Financial Condition

DOW INC. (DOW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991enrschedules2q26.htm EX-99.1 Document Exhibit 99.1 July 23, 2026 Dow reports second quarter 2026 results FINANCIAL HIGHLIGHTS • Net sales were $12.1 billion, up 20% year-over-year, reflecting increases in all operating segments and regions. • Local price incre

Original reporting
Published Jul 23, 2026, 10:59 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 11:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$DOW
Bullish
high confidence
Mentioned
$DOW
Relevance
8/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$DOWBullishMed
01

Why it matters

The filing updates the company’s expected 2026 benefits from Transform to Outperform by approximately $200M more, while reporting strong YoY improvements in operating EBIT, operating EPS, and operating cash flow.

02

Market read

Traders can reassess near-term earnings power and margin/cash-flow trajectory based on the reported quarter and the updated 2026 self-help benefit outlook.

03

What to watch

Operating EPS excludes significant items and includes tax adjustments tied to NOVA Chemicals; also higher fixed costs and turnaround/shutdown costs in Performance Materials & Coatings may reappear in future quarters.

Relevance 8/10Novelty 8/10Timing: today’s SEC 8-K, ahead of next earnings cycle

Background

This is Dow’s SEC Form 8-K with Exhibit 99.1 covering second-quarter 2026 results and management commentary on its Transform to Outperform program.

Company-level read

Ticker impact

$DOWBullishHigh confidence
Context

Dow reported 2Q26 net sales of $12.1B (+20% YoY) and GAAP EPS of $0.99, with operating EPS $1.44 versus a year-ago loss.

Expected impact

Near-term upside bias as the earnings beat and increased self-help benefit outlook support margin and cash-flow expectations.

Evidence & confidence

The filing provides multiple fresh datapoints (sales, GAAP/operating EPS, operating EBIT, operating cash flow) and a specific updated annual benefits expectation of about $200M more.

Market effects

Reinforces pricing strength and cost-action execution in chemicals, potentially supporting sentiment for downstream plastics and intermediates.

Mentions EMEAI and Asia Pacific volume impacts from the Middle East conflict, highlighting regional demand volatility.

Global polyethylene and olefins price tailwinds appear to be driving results, relevant to broader commodity-linked chemical margins.

Counterpoint

Earnings strength is heavily price and self-help driven, while volume is down and maintenance activity plus regional conflict impacts could cap sustainability.

Key entities

  • DOW

    Dow Inc., reporting 2Q26 results and updating expected 2026 benefits from Transform to Outperform.

  • Transform to Outperform

    Dow’s self-help initiative referenced as driving earnings improvement and updated benefit expectations for 2026.

  • NOVA Chemicals

    Referenced in connection with an income tax adjustment associated with a payment.

Related articles

$LYBMed

Iran conflict lifts chemical earnings

Iran conflict and Strait of Hormuz disruption have tightened petrochemical supply, enabling major chemical makers to raise prices. LyondellBasell reported Q2 adjusted earnings of $1.4B, up nearly 600% YoY. Dow sales rose 19.7% and swung to profit. BASF profits rose 167% with 16% higher sales. Executives warn the boost may be temporary.

$JNJMed

J&J, Dow Chemical Lose Bid to Preserve Asbestos Claims Data

The Delaware Supreme Court overturned a lower court ruling that would have allowed asbestos litigation to proceed against settlement trusts planning to delete claims data older than a year. The decision affects Johnson & Johnson and Dow Chemical, which use the data to argue for lower payouts by showing some claimants had other sources of recovery.

$DOWMedAI 8/10

Dow Reports Net Income In Q2

Dow (DOW) reported Q2 GAAP net income of $802 million versus a $801 million loss a year earlier. GAAP EPS was $0.99 versus a loss of $1.18. Operating EBIT rose to $1.6 billion, and operating profit per share was $1.44. Net sales increased 20% to $12.1 billion; volume fell 1%. Shares were up 3.49% premarket at $32.32.